{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T15:49:24Z","timestamp":1769096964841,"version":"3.49.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajicjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Infection Control"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ajic.2019.04.175","type":"journal-article","created":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T01:57:15Z","timestamp":1560823035000},"page":"1284-1289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Syndrome-specific versus prospective audit and feedback interventions for reducing use of broad-spectrum antimicrobial agents"],"prefix":"10.1016","volume":"47","author":[{"given":"Krutika N.","family":"Mediwala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph E.","family":"Kohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. Brandon","family":"Bookstaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4161-9577","authenticated-orcid":false,"given":"Julie Ann","family":"Justo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana","family":"Rac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kendall","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lora","family":"Lashkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangita","family":"Dash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Majdi N.","family":"Al-Hasan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajic.2019.04.175_bib0001","unstructured":"Centers for Disease Control and Prevention. National strategy for combating antibiotic-resistant bacteria. 2014. Available from: www.cdc.gov\/drugresistance\/pdf\/carb_national_strategy.pdf. Accessed June 15, 2018."},{"key":"10.1016\/j.ajic.2019.04.175_bib0002","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1001\/jamainternmed.2016.5651","article-title":"Estimating national trends in inpatient antibiotic use among US hospitals from 2006 to 2012","volume":"176","author":"Baggs","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ajic.2019.04.175_bib0003","first-page":"352","article-title":"Multidrug- and carbapenem-resistant Pseudomonas aeruginosa in children, United States, 1999-2012","volume":"6","author":"Logan","year":"2017","journal-title":"J Pediatric Infect Dis Society"},{"key":"10.1016\/j.ajic.2019.04.175_bib0004","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1093\/cid\/ciw118","article-title":"Implementing an antibiotic stewardship program: guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America","volume":"62","author":"Barlam","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2019.04.175_bib0005","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/cid\/ciw780","article-title":"What is the more effective antibiotic stewardship intervention: preprescription authorization or postprescription review with feedback?","volume":"64","author":"Tamma","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2019.04.175_bib0006","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1177\/0018578717720506","article-title":"Development of institutional guidelines for management of gram-negative bloodstream infections: incorporating local evidence","volume":"52","author":"Nimmich","year":"2017","journal-title":"Hosp Pharm"},{"key":"10.1016\/j.ajic.2019.04.175_bib0007","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00189-17","article-title":"Cumulative effect of an antimicrobial stewardship and rapid diagnostic testing bundle on early streamlining of antimicrobial therapy in gram-negative bloodstream infections","volume":"61","author":"Bookstaver","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2019.04.175_bib0008","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1017\/ice.2016.292","article-title":"Clinical risk score for prediction of extended-spectrum beta-lactamase-producing Enterobacteriaceae in bloodstream isolates","volume":"38","author":"Augustine","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2019.04.175_bib0009","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s15010-018-1147-z","article-title":"Risk factors for pneumonia due to beta-lactam-susceptible and beta-lactam-resistant Pseudomonas aeruginosa: a case-case-control study","volume":"46","author":"Al-Jaghbeer","year":"2018","journal-title":"Infection"},{"key":"10.1016\/j.ajic.2019.04.175_bib0010","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.3390\/antibiotics8010015","article-title":"Utility of combination antimicrobial therapy in adults with bloodstream infections due to Enterobacteriaceae and non-fermenting Gram-negative bacilli based on in vitro analysis at two community hospitals","volume":"8","author":"Foster","year":"2019","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ajic.2019.04.175_bib0011","unstructured":"Justo J, Dickert EL, Kohn J, Bookstaver PB. Comparative risk of acute kidney injury in patients receiving vancomycin monotherapy or vancomycin and beta-lactam combination therapy [abstract]. 54th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC: 5-9 September 2014; Abstract #2544."},{"key":"10.1016\/j.ajic.2019.04.175_bib0012","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1128\/AAC.03011-15","article-title":"Epidemiology of acute kidney injury among patients receiving concomitant vancomycin and piperacillin-tazobactam: opportunities for antimicrobial stewardship","volume":"60","author":"Karino","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajic.2019.04.175_bib0013","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.diagmicrobio.2016.09.017","article-title":"Differential effect of prior beta-lactams and fluoroquinolones on risk of bloodstream infections secondary to Pseudomonas aeruginosa","volume":"87","author":"Hammer","year":"2017","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ajic.2019.04.175_bib0014","unstructured":"Tucker K, Lashkova L, Flemming T, Justo J, Kohn J, Al-Hasan MN, et al. Impact of antimicrobial stewardship initiatives on carbapenem utilization and antimicrobial resistance [abstract]. 55th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Diego, CA: 17-21 September 2015; Abstract #2243."},{"key":"10.1016\/j.ajic.2019.04.175_bib0015","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/phar.2054","article-title":"Impact of penicillin allergy on empirical carbapenem use in gram-negative bloodstream infections: an antimicrobial stewardship opportunity","volume":"38","author":"Al-Hasan","year":"2018","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ajic.2019.04.175_bib0016","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2146\/ajhp100272","article-title":"Moving antimicrobial stewardship from restriction to facilitation","volume":"68","author":"Martin","year":"2011","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ajic.2019.04.175_bib0017","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1017\/ice.2018.10","article-title":"Electronically available comorbid conditions for risk prediction of healthcare-associated Clostridium difficile infection","volume":"39","author":"Harris","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ajic.2019.04.175_bib0018","article-title":"Role of early de-escalation of antimicrobial therapy on risk of Clostridioides difficile infection following Enterobacteriaceae bloodstream infections","author":"Seddon","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajic.2019.04.175_bib0019","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/cid\/ciy075","article-title":"The standardized antimicrobial administration ratio: a new metric for measuring and comparing antibiotic use","volume":"67","author":"van Santen","year":"2018","journal-title":"Clin Infect Dis"}],"container-title":["American Journal of Infection Control"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655319304456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196655319304456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T05:51:54Z","timestamp":1759297914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196655319304456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0196655319304456"],"URL":"https:\/\/doi.org\/10.1016\/j.ajic.2019.04.175","relation":{},"ISSN":["0196-6553"],"issn-type":[{"value":"0196-6553","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Syndrome-specific versus prospective audit and feedback interventions for reducing use of broad-spectrum antimicrobial agents","name":"articletitle","label":"Article Title"},{"value":"American Journal of Infection Control","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajic.2019.04.175","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}